SofWave Medical Ltd. (TLV:SOFW)
Israel · Delayed Price · Currency is ILS · Price in ILA 3,832.00
+112.00 (3.01%)
Aug 28, 2026, 1:45 PM IDT
SofWave Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 8.85 | 5.49 | -4.55 | -8.28 | -19.53 | -6.83 |
Depreciation & Amortization | 2.08 | 1.81 | 1.79 | 1.51 | 1.12 | 0.36 |
Loss (Gain) From Sale of Investments | 0.27 | -0.17 | - | - | - | - |
Stock-Based Compensation | 1.71 | 2.32 | 2.4 | 2.28 | 5.14 | 5.04 |
Other Operating Activities | -1.24 | -1.07 | -0.29 | -0.71 | 2.2 | -2.27 |
Change in Accounts Receivable | -1.76 | 1.05 | -0.84 | -3.32 | 0.72 | -4.85 |
Change in Inventory | -1.18 | -0.34 | -2.11 | -1.62 | -3.06 | -1.9 |
Change in Accounts Payable | 2.44 | 0.94 | 0.85 | 2.79 | -2.45 | 4.92 |
Change in Other Net Operating Assets | 2.67 | 3.27 | 0.35 | 1.05 | 5.17 | 1.13 |
Operating Cash Flow | 13.85 | 13.3 | -2.4 | -6.31 | -10.69 | -4.4 |
Operating Cash Flow Growth | 385.35% | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.78 | -0.53 | -0.28 | -0.41 | -0.45 | -0.82 |
Investment in Securities | -9.99 | -0.52 | - | - | - | - |
Other Investing Activities | 0.88 | 0.64 | 0.53 | 0.82 | 0.19 | -0.13 |
Investing Cash Flow | -9.9 | -0.42 | 0.25 | 0.41 | -0.26 | -0.95 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.81 | -0.66 | -0.65 | -0.69 | -0.21 |
Net Debt Issued (Repaid) | -0.87 | -0.81 | -0.66 | -0.65 | -0.69 | -0.21 |
Issuance of Common Stock | 0.9 | 0.38 | 0.33 | 0 | 0.03 | 46.96 |
Other Financing Activities | - | - | -0.28 | -1.08 | -0.69 | -0.1 |
Financing Cash Flow | 0.04 | -0.43 | -0.62 | -1.72 | -1.35 | 46.64 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.75 | 0.69 | -0.04 | 0.04 | -1.9 | 2.27 |
Net Cash Flow | 4.75 | 13.13 | -2.81 | -7.58 | -14.2 | 43.57 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 13.07 | 12.76 | -2.67 | -6.71 | -11.14 | -5.22 |
Free Cash Flow Growth | 402.58% | - | - | - | - | - |
Free Cash Flow Margin | 12.53% | 14.56% | -4.48% | -13.34% | -31.27% | -23.90% |
Free Cash Flow Per Share | 0.33 | 0.32 | -0.08 | -0.20 | -0.33 | -0.22 |
Levered Free Cash Flow | 12.95 | 13.3 | 0.84 | -3.04 | -4.75 | -1.04 |
Unlevered Free Cash Flow | 13.04 | 13.34 | 0.87 | -3 | -4.63 | -0.97 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 0.08 | 0.19 | 0.24 | - | - | - |
Change in Working Capital | 2.17 | 4.92 | -1.75 | -1.11 | 0.38 | -0.7 |